The compound 2-bromopalmitate, a small-molecule inhibitor of palmitoylation, blocks the palmitoylation of PD-L1 and effectively induces lysosomal degradation of PD-L1 in tumor cells, thus enhancing the cytotoxicity of tumor-specific T cells24,138. The gene discussed is CD274; the disease is neoplasm.